Ireland's MuteButton scores funding for tinnitus device

Spin-out company MuteButton has secured €200,000 (approximately $289,500) in funding from Enterprise Ireland, allowing it to accelerate large-scale trials of its tinnitus treatment device and increase its workforce from four to 20 by 2013. Story

Suggested Articles

The immunoassay will measure neurofilament light chain protein levels, found in the blood and cerebrospinal fluid, and linked to nerve damage.

Emmecell aims to make corneal transplant surgery, which can take up to a year to heal from and fails up to 20% of the time, a relic of the past.

Seven developers will provide digital health solutions aimed at the COVID-19 pandemic, including smartphone apps, wearables and big data programs.